| 英文名称 |
中文名称 |
CAS号 |
操作 |
| EG01377 2HCl |
EG01377二盐酸盐 |
2749438-61-5 |
详细
|
| LEI-515 |
|
|
详细
|
| DIMETHINDENE |
二甲茚定 |
5636-83-9 |
详细
|
| Trans resveratrol |
trans Resveratrol 3-Sulfate Sodium Salt |
858127-11-4 |
详细
|
| CP-775146 |
2-Methyl-2-[3-[(3S)-1-[2-[4-(1-methylethyl)phenyl]acetyl]-3-piperidinyl]phenoxy]-propanoicacid |
702680-17-9 |
详细
|
| AMD 3465 |
1G,10G,100G,1KG |
185991-24-6 |
详细
|
| Bay 41-4109 |
298708-81-3 |
298708-81-3 |
详细
|
| Ethidium homodimer |
乙二胺联二丙锭氯化物二盐酸盐 |
61926-22-5 |
详细
|
| CARBACYCLIN |
CARBACYCLIN |
69552-46-1 |
详细
|
| Arginase II（BEC hydrochloride） |
S-(2-硼酸基乙基)-L-半胱氨酸 |
63107-40-4 |
详细
|
| Pyroxamide |
N-羟基-N'-3-吡啶基辛二酰胺 |
382180-17-8 |
详细
|
| RP101988 |
|
|
详细
|
| SACLAC |
化合物 SACLAC |
2248703-42-4 |
详细
|
| (S,R,S)-AHPC-C3-NH2 hydrochloride/VH032-C3-NH2 |
|
2940858-65-9 |
详细
|
| VRT-532 |
4-METHYL-2-(5-PHENYL-1H-PYRAZOL-3-YL)PHENOL |
38214-71-0 |
详细
|
| CP 316311 |
175139-41-0 |
175139-41-0 |
详细
|
| MI-773 |
(2'R,3S,4'S,5'R)-6-氯-4'-(3-氯-2-氟苯基)-2'-(2,2-二甲基丙基)-1,2-二氢-N-(反式-4-羟基环己基)-2-氧代螺[3H-吲哚-3,3'-吡咯烷]-5'-甲酰胺 |
1303607-07-9 |
详细
|
| DH 97 |
化合物 DH-97 |
343263-95-6 |
详细
|
| RK-33 |
RK-33 |
1070773-09-9 |
详细
|
| CL097 hydrochloride |
化合物CL097 |
1026249-18-2 |
详细
|
| ZXH-3-26 |
ZXH 3-26 |
2243076-67-5 |
详细
|
| Darifenacin |
达非那新 |
133099-04-4 |
详细
|
| 5-Isobenzofurancarboxylic acid, 1,3-dihydro-1,3-dimethoxy-, 2,5-dioxo-1-pyrrolidinyl ester |
1,3-二氢-1,3-二甲氧基-5-异苯并呋喃羧酸 2,5-二氧杂-1-吡咯烷基酯 |
1092559-67-5 |
详细
|
| CSN5i-3 |
化合物 T10895 |
2375740-98-8 |
详细
|
| MRK-898 |
|
461450-30-6 |
详细
|
| Radezolid |
雷得唑来 |
869884-78-6 |
详细
|
| GCN2-IN-1/A-92 |
1448693-69-3 |
1448693-69-3 |
详细
|
| DMCM hydrochloride |
6,7-二甲氧基-4-乙基-BETA-咔啉-3-羧酸甲酯 |
82499-00-1 |
详细
|
| Giredestrant tartrate |
Estrogen receptor antagonist 1 |
2407529-33-1 |
详细
|
| Pelcitoclax/APG-1252 |
APG-1252 |
1619923-36-2 |
详细
|
| PAD2-IN-1 hydrochloride |
|
2095109-82-1 |
详细
|
| MAGL-IN-4 |
His121 ARG57 |
2135785-20-3 |
详细
|
| JXL-069 |
|
2260696-63-5 |
详细
|
| Piperazine, 1-ethyl-2-methyl-, hydrochloride (1:2), (2S)- |
(S)-1-乙基-2-甲基哌嗪二盐酸盐 |
2664977-66-4 |
详细
|
| TH-Z816 |
TH-Z816中间体 |
2847881-42-7 |
详细
|
| DMP 696 |
202578-52-7 |
202578-52-7 |
详细
|
| SLF1081851 hydrochloride |
化合物 SLF1081851 HYDROCHLORIDE |
2999629-35-3 |
详细
|
| 1,2-Dioleoyl-sn-glycerol |
1,2-二油酰基-SN-甘油 |
24529-88-2 |
详细
|
| DDD85646 |
DDD85646 |
1215010-55-1 |
详细
|
| Delgocitinib |
迪高替尼 |
1263774-59-9 |
详细
|
| BN82002 |
396073-89-5 |
396073-89-5 |
详细
|
| Dalvastatin |
达伐他汀 |
132100-55-1 |
详细
|
| Arachidonylcyclopropylamide/ACPA |
ACPA |
229021-64-1 |
详细
|
| MK-3402 |
化合物 MK-3402 |
2058151-78-1 |
详细
|
| SARS-CoV-2-IN-6 |
化合物 SARS-COV-2-IN-6 |
2725749-22-2 |
详细
|
| HC-258 |
HC-258 |
|
详细
|
| M1002 |
化合物 M1002 |
823830-85-9 |
详细
|
| 4-chloro-N-(6,8-dibromo-2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl)benzamide |
化合物 DS1 |
372497-52-4 |
详细
|
| KJ Pyr 9 |
KJ PYR 9 |
581073-80-5 |
详细
|
| Selatinib |
Selatinib |
1275595-86-2 |
详细
|
| Dual DDR1 and DDR2 inhibitor 5n |
Dual DDR1 and DDR2 inhibitor 5n |
2241813-33-0 |
详细
|
| GB-110 |
GB-110 |
1252806-70-4 |
详细
|
| Syntide 2 TFA |
Syntide 2 (TFA) |
|
详细
|
| TDM-105795 |
|
1639993-01-3 |
详细
|
| MSA-2 dimer |
MSA-2 DIMER |
2377881-92-8 |
详细
|
| GLPG3970 |
3,4-二氢-8-甲氧基-6-[7-[2-(4-吗啉基)乙氧基]咪唑并[1,2-A]吡啶-3-基]-2-(2,2,2-三氟乙基)-1(2H)-异喹啉酮 |
2403733-82-2 |
详细
|
| CONIVAPTAN |
CONIVAPTAN |
210101-16-9 |
详细
|
| ABN401 |
化合物 ABN401 |
2242563-15-9 |
详细
|
| 3-(tert-Butylthio)pyridin-2-amine |
3-叔丁硫基-2-氨基吡啶 |
551950-47-1 |
详细
|
| Zongertinib/BI 1810631 |
宗格替尼 |
2728667-27-2 |
详细
|
| SB1-G-187 |
|
2769753-18-4 |
详细
|
| SGI-110 |
化合物 T16876 |
929901-49-5 |
详细
|
| 11-Dehydro ThroMboxane B2 |
11-脱氢凝血烷B2 |
67910-12-7 |
详细
|
| 11-deoxy Prostaglandin E2 |
11-DEOXY PROSTAGLANDIN E2 |
35536-53-9 |
详细
|
| JNJ-54175446 |
|
627902-21-9 |
详细
|
| GPR84 antagonist 8 |
GPR84 ANTAGONIST 8 |
1445846-30-9 |
详细
|
| ABBV-4083 |
ABBV-4083 |
1809266-03-2 |
详细
|
| 13,14-Dihydro-15-keto prostaglandin D2 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
详细
|
| Diflorasone diacetate |
醋酸双氟拉松 |
33564-31-7 |
详细
|
| TP-1454 |
|
2490276-04-3 |
详细
|
| MK-1084 |
|
2641216-67-1 |
详细
|
| RESIQUIMOD |
雷西莫特 |
144875-48-9 |
详细
|
| 2-Nitro-5-tosylfuran |
NSC697923 |
343351-67-7 |
详细
|
| PF-06372865 |
PF-06372865 |
1614245-70-3 |
详细
|
| DO34 |
DO-34
(DO34) |
1848233-58-8 |
详细
|
| Ulonivirine/MK-8507 |
MK-8507 |
1591823-76-5 |
详细
|
| Dalpiciclib/SHR-6390 |
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-piperidinyl)-2-pyridinyl]amino]- |
1637781-04-4 |
详细
|
| Icapamespib |
ICAPAMESPIB |
1000999-96-1 |
详细
|
| DDO-2728 |
|
|
详细
|
| O-HYDROXY ATORVASTATIN LACTONE |
O-羟基阿伐他汀内酯 |
163217-74-1 |
详细
|
| Vafidemstat/ORY-2001 |
VAFIDEMSTAT |
1357362-02-7 |
详细
|
| Sparfosic acid trisodium |
Sparfosic acid trisodium |
70962-66-2 |
详细
|
| DK-507K |
|
364069-14-7 |
详细
|
| CQ211 |
化合物 CQ211 |
2648986-65-4 |
详细
|
| DF2593A |
|
2351103-43-8 |
详细
|
| 1-[(E)-octadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-octadec-9-enoate |
|
14268-17-8 |
详细
|
| NA |
|
2743427-31-6 |
详细
|
| Ivachtin |
IVACHTIN |
745046-84-8 |
详细
|
| GSK602 |
GSK602 |
1714146-59-4 |
详细
|
| Pazufloxacin Impurity 16 |
Pazufloxacin Impurity 16 |
165071-10-3 |
详细
|
| sPLA2 Inhibitor |
SPLA2 INHIBITOR |
393569-31-8 |
详细
|
| RAD51-IN-3 |
|
2301084-99-9 |
详细
|
| CV-6209 |
CV 6209 |
100488-87-7 |
详细
|
| AB-836 |
AB-836 |
2445597-31-7 |
详细
|
| Lorundrostat/MT-4129 |
化合物 LORUNDROSTAT |
1820940-17-7 |
详细
|
| 2-Cyano-N-(furan-2-ylmethyl)acetamide |
|
2914919-85-8 |
详细
|
| 10,10-difluorothromboxane A2 |
|
121573-36-2 |
详细
|
| 2,4,17,19-Tetraazaeicosanediimidamide, 3,18-diimino- |
|
2773484-02-7 |
详细
|
| PROTAC tubulin-Degrader-1(compound W13) |
|
|
详细
|
| Datiscetin |
橡精 |
480-15-9 |
详细
|